为评估 TFPI 对慢性肾病(CKD)和糖尿病患者动脉粥样硬化血栓事件(ATE)的预测能力,研究发现 TFPI 在 CKD 患者中可预测 ATE,意义重大。 在心血管疾病(CVD)的防治领域,寻找精准预测心血管风险的生物标志物一直是研究热点。想象一下,我们若能提前知晓哪些 ...
The once-weekly anti-TFPI antibody has been cleared by the European Commission for adults and adolescents aged 123 and over with severe haemophilia A or B, without inhibitors, becoming the first ...
The results of the Explorer7 trial showed that concizumab – an anti-tissue factor pathway inhibitor (TFPI) antibody – reduced the number of treated bleeds in patients by 86% when given as a ...